Skip to main content
Log in

According to a US cost analysis,* inpatient candidaemia treatment is “extremely costly”

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Gagne JJ, Breitbart RE, Maio V, Horn DL, Hartmann C, Swanson R, Goldfarb NI.Costs associated with candidemia in a hospital setting. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy: 443, 27 Sep 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

According to a US cost analysis,* inpatient candidaemia treatment is “extremely costly”. Pharmacoecon. Outcomes News 516, 6 (2006). https://doi.org/10.2165/00151234-200605160-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605160-00012

Keywords

Navigation